ACG's 2014 Annual Scientific Meeting Annual Scientific Meeting

Transcription

ACG's 2014 Annual Scientific Meeting
Annual Scientific Meeting
Monday through Wednesday, October 20 through 22, 2014 • Terrace Ballroom
Join GI physicians from around the U.S. and the world for the ACG Annual Scientific Meeting. The meeting promises to deliver the latest
clinical information on timely topics in gastroenterology. As an ACG member, you can attend the three-day Annual Meeting for free – there
is no registration fee. Choose from 11 symposia, multiple networking events, and see the latest advances in technology and therapeutics
from exhibitors from around the globe. Additional breakfast sessions, 17 in total, will be offered for a nominal fee. Register today!
Be sure to visit poster presentations in the Exhibit Hall on Sunday, October 19th beginning at 3:30 pm, and enjoy the Exhibit Hall Opening
Reception beginning at 5:15 pm on Sunday.
Program Description
Returning this year is the Endoscopy Video Forum, “Live
from Philly! The 2nd Annual Endoscopy Video Forum.” The
Forum will feature the best video presentations submitted
from colleagues from across the U.S. and around the world.
Submitted during ACG’s Call for Abstracts and peer-reviewed
and selected for presentation, the cases will feature endoscopy
techniques, challenging or unique cases, and cases in the area
of GI endoscopy. During the session, the audience, along with
the Moderators, will vote to select the best video of ACG 2014.
The field of gastroenterology and hepatology continues to
see advancements in multiple areas relating to diagnostic
measures, therapeutic options and technology. In order to
provide appropriate and top-quality patient care, the clinician is
challenged to stay abreast of the changes and advancements
affecting the management of many gastrointestinal and liver
disease states. Throughout the three-day Annual Meeting, you
will be exposed to updates in a variety of topics, including
biologic therapy in IBD, hepatitis C, acute and chronic
pancreatitis, IBS, colonoscopy, the refractory esophageal patient,
case studies in IBD management, the inpatient hepatology
consult, the human microbiome, and more.
The Annual Scientific Meeting program is designed primarily
for physicians in gastroenterology and hepatology, as well as
physician assistants, nurse practitioners and other advanced
practice healthcare professionals interested in the latest
information on state-of-the-art treatment of these illnesses.
Eleven scientific plenary symposia will allow attendees to
hear lecture presentations from experts and to participate in
interactive question and answer sessions with the faculty. In
addition, 17 optional scientific breakfast sessions will be offered,
where a smaller setting allows for heightened interaction with the
speakers and greater audience involvement.
Accreditation
The American College of Gastroenterology is accredited by
the Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians.
Many sessions will use expert panel discussions in debate and
case-based formats.
The American College of Gastroenterology designates this live
activity for a maximum of 16.25 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the
extent of their participation in the activity.
Download ACG 2014 slides to your Apple
or Android smart device with eventScribe!
23
ANNUAL
MEETING
Follow along with the presenter when you download slides
using the eventScribe app by CadmiumCD. The eventScribe
app, native to Apple and Android devices including tablets,
phones, and Kindle Fire, can be downloaded in advance and
used onsite during the meeting. eventScribe lets you take
notes next to each slide, highlight information and draw on
each slide. Save your notes to reference after the meeting.
annual scientific
meeting slides
will be available on
course available on
Look for this symbol to
see if eventScribe slide
downloads are available.
For more information on ACG 2014 and to register, visit www.acgmeetings.gi.org.
Annual Scientific Meeting Agenda – Monday, October 20
Monday, October 20, 2014
breakfast c: GI Disease in Transitioning Teenagers:
Adults Aren't Big Kids
6:30 am – 6:00 pm
6:00 am – 4:45 pm
Registration (Broad Street Atrium)
moderator: Sandeep K. Gupta, MD, FACG
Cystic Fibrosis
Drucy S. Borowitz, MD
Discuss issues that carry over with patients as they transition into
adult practice, including nutrition and liver disease.
6:30 am – 7:45 am
OPTIONAL Breakfast Sessions
Cost is $60 per person/per session. Separate registration required. A USB containing all ACG 2014 Breakfast Sessions submissions will be provided to attendees registered for any Breakfast Session. See page 124 for registration information.
IBD
Judith R. Kelsen, MD
breakfast a:
Outline how patients with childhood-onset IBD are different from adultonset disease.
moderator: Ryan Madanick, MD
EoE
Sandeep K. Gupta, MD, FACG
GIs in the Digital Age: The Power of
Social Media
Describe issues faced by teenagers with GI disease including diet
compliance, medication use and independent access to health-care.
To Socialize or Not to Socialize: The Pros and Cons of Social Media
Sites
Ryan Madanick, MD
breakfast d: A
Explain the threats to professionalism that involvement in social media
poses and how these threats can be minimized, and monitor and begin to
manage your own digital footprint.
Conditions
moderator: Philip O. Katz, MD, FACG
Reputation Management: How to Use Your Online Brand to Bring in
New Patients
Kenneth Brown, MD
GERD and Barrett’s
Philip O. Katz, MD, FACG
Explain how social media can improve patient care and how your online
brand can be used to bring in new patients.
Formulate a cost-effective approach for the management of GERD and
Barrett’s esophagus.
Case Studies in Social Media: Dos and Don’ts
David T. Rubin, MD, FACG
Constipation
Amy E. Foxx-Orenstein, DO, FACG
Select a social media platform appropriate for personal and professional
needs.
breakfast b: Atypical
Cost-effective Approach to Common GI
Assess the need for diagnostic testing in patients with chronic constipation.
Dyspepsia
Brian E. Lacy, MD, PhD, FACG
Colitides
Identify a cost-effective approach for the treatment of dyspepsia.
moderator: Darrell S. Pardi, MD, FACG
breakfast e:
Endoscopy 101: Esophageal and
Anorectal Motility, and Hands-on
Microscopic Colitis: What’s New in Diagnosis and Management
Darrell S. Pardi, MD, FACG
Identify current and new methods to detect and treat microscopic colitis.
moderator: Felice Schnoll-Sussman, MD, FACG
The Spectrum of Diverticular Disease: SCAD, SUDD
Brennan M. R. Spiegel, MD, MSHS, FACG
Esophageal Manometry
Felice Schnoll-Sussman, MD, FACG
Utilize diagnostic tools to define the spectrum of diverticular diseases.
Interpret common esophageal motility problems, followed by a hands-on
demonstration.
Ischemic Colitis
Lawrence J. Brandt, MD, MACG
Anorectal Manometry
Satish S. C. Rao, MD, PhD, FACG
Summarize the pathophysiology and know the methods for diagnosing and
treating ischemic colitis.
Interpret common anorectal motility problems, followed by a hands-on
demonstration.
Following the didactic lectures, attendees will participate in a hands-on
session taking place in the Hands-on Workshop Center from 7:50 am9:00 am.
24
6:00 am – 4:45 pm
7:50 am – 6:00 pm
Scientific Meeting
7:50 am – 8:00 am Opening Remarks
8:00 am – 9:00 am
ModeratoRS:
Paris Descartes et Hôpital, Paris, France, Hopital Saint Joseph,
Marseille, France, Complejo Hospitalario Universitario A Coruña,
A Coruña, Spain, Hospital Universitario La Fe, Valencia, Spain,
AbbVie, Inc., North Chicago, IL
(Terrace Ballroom)
Harry E. Sarles, Jr., MD, FACG
ACG President
9:00 am – 9:30 am
President’s Address
(Terrace Ballroom)
Introduced by:
Stephen B. Hanauer, MD, FACG
ACG President-Elect
PRESIDENT'S Plenary Session 1
(Terrace Ballroom)
John R. Saltzman, MD, FACG
9:30 am – 10:30 am 1. Dronabinol Increases Pain Threshold in Non-Cardiac Chest
Pain: A Double Blind Placebo Controlled Trial
2014 ACG Auxiliary Award (Trainee)
Zubair Malik, MD, Levant Bayman, MSc, Jessica Valestine, BSc,
Ron Schey, MD, Temple University Hospital, Philadelphia, PA,
University of Iowa Hospitals and Clinics, Iowa City, IA
ModeratoRS:
PRESIDENT'S Plenary Session 2
(Terrace Ballroom)
John R. Saltzman, MD, FACG
6. Capnographic Monitoring Does Not Improve Detection of
Hypoxemia in Colonoscopy With Moderate Sedation. A Randomized, Controlled Trial
2014 ACG Fellow Award
Paresh P. Mehta, MD, Gursimran Kochhar, MD, Mazen Albeldawi,
MD, Brian Kirsh, MD, Maged K. Rizk, MD, Brian Putka, MD,
Binu John, MD, Yinghong Wang, MD, Nicole Breslaw, MD, John
J. Vargo, MD, FACG, Cleveland Clinic, Cleveland, OH
2. Metal Versus Plastic for Pancreatic Pseudocyst Drainage:
Clinical Outcomes and Success
Reem Z. Sharaiha, MD, MSc, Ersilia M. DeFilippis, MD, Prashant
Keida, MD, Christine Boumitri, MD, Huei-Wen Lim, MD, Eugene
Han, MD, Harkarit Singh, MD, Saad S. Ghumman, MD, Monica
Gaidhane, MD, Thomas Kowalski, MD, David Loren, MD, Michel
Kahaleh, MD, FACG, Ali Siddiqui, MD, Weill Cornell Medical Center, New York, NY, Thomas Jefferson University, Philadelphia, PA
7. Young-Onset Colorectal Cancer: A More Aggressive Disease
on the Rise
2014 ACG Colorectal Cancer Prevention Award
Xi E. Zheng, MD, PhD, Heather Yeo, MD, MHS, Doron Betel,
PhD, Manish A. Shah, MD, Weill Cornell Medical College, New
York, NY
3. Gender Differences in Research Productivity, Academic Rank
and Career Duration Among U.S. Academic Gastroenterology
Faculty
2014 ACG/Naomi Nakao Gender-Based Research Award
Sarah J. Diamond, MD, Brintha K. Enestvedt, MD, MBA, Charles
Thomas, MD, Sima Desai, MD, Reshma Jagsi, MD, Colleen
Schmitt, MD, Oregon Health and Science University, Portland,
OR, University of Michigan, Ann Arbor, MI, Galen Medical Group,
Chattanooga, TN
8. Impact of Retroflexion Versus Second Forward View Examination of the Right Colon on Adenoma Detection: A Multicenter
Randomized Controlled Trial
Vladimir M. Kushnir, MD, Young Oh, MD, Thomas Hollander,
BS, Chien-Huan Chen, MD, PhD, Gregory S. Sayuk, MD, MPH,
Nicholas Davidson, MD, FACG, Daniel Mullady, MD, Faris M.
Murad, MD, Noura M. Sharabash, MD, Eric Ruettgers, MSN, RN,
ANP-BC, Themistocles Dassopoulos, MD, Jeffrey J. Easler, MD, C.
Prakash Gyawali, MD, FACG, Steven A. Edmundowicz, MD, Dayna
S. Early, MD, FACG, Washington University School of Medicine,
St. Louis, MO, Medical College of Wisconsin, Milwaukee, WI
9. Colonoscopy Is Associated With a Reduced Risk of Colon
Cancer and Mortality in Patients With Inflammatory Bowel
Diseases
2014 ACG Auxiliary Award (Member/Fellow)
Ashwin Ananthakrishnan, MD, MPH, Andrew Cagan, BS, Tianxi
Cai, PhD, Vivian Gainer, MS, Stanley Shaw, MD, PhD, Susanne
Churchill, PhD, Elizabeth Karlsin, MD, MPH, Shawn Murphy,
MD, PhD, Isaac Kohane, MD, PhD, Katherine Liao, MD, MPH,
Massachusetts General Hospital, Boston, MA, Brigham and
Women’s Hospital, Boston, MA, Harvard School of Public
Health, Boston, MA, Partners Healthcare, Boston, MA
5. Normalization of Liver-Related Laboratory Parameters in HCV
Genotype 1-Infected Patients With Cirrhosis After Treatment
With ABT-450/R/Ombitasvir, Dasabuvir and Ribavirin
Gregory Everson, MD, Samuel Lee, MD, Stefan Zeuzem, MD,
Pietro Andreone, MD, Stanislas Pol, MD, Marc Bourlière, MD,
Angeles Castro, MD, PhD, Marina Berenguer, MD, Sandra Lovell,
PhD, Marcos Pedrosa, MD, PhD, Roger Trinh, MD, MPH, University of Colorado Denver and Hospital, Aurora, CO, University of
Calgary, Calgary, Alberta, Canada, J.W. Goethe University, Frankfurt, Germany, University of Bologna, Bologna, Italy, Université
ANNUAL
MEETING
4. SVR12 of 99% Achieved With a Ribavirin-Free Regiment
of ABT-450/r/Ombitasvir and Dasabuvir in HCV Genotype 1bInfected Patients
2014 ACG International Award
Andreas Maieron, MD, Massimo Puoti, MD, Jeffrey Enejosa,
MD, Ziv Ben-Ari, MD, Gunnar Norkrans, MD, Manuel RomeroGomez, MD, Wangang Xie, MD, PhD, Daniel Cohen, MD, Thomas
Podsadecki, MD, Pietro Andreone, MD, Elisabeth Hospital, Linz,
Austria, A.O. Ospedale Niguarda Ca Granda, Milan, Italy, AbbVie, Inc., North Chicago, IL, The Chaim Sheba Medical Center,
Tel Hashomer, Israel, Sahlgrenska University Hospital, Göteborg,
Sweden, Hospital Universitario Nuestra Senora De Valme, Seville,
Spain, University of Bologna, Bologna, Italy
10. The Effect of Immunosuppressive Therapy on Cardiovascular Disease in Patients With Inflammatory Bowel Disease
Sudeep D. Thapa, MD, Hiba Hadid, MD, Syed-Mohammed Jafri,
MD, Mohammed Imam, DO, Jason Schairer, MD, Internal Medicine, Henry Ford Hospital, Detroit, MI
25
10:00 am – 4:30 pm
Exhibit Hall Opens
10:00 am – 4:30 pm
Hands-on Workshop Center
Plenary Session 1: Functional Bowel Disorder/Pediatrics
(Exhibit Halls DE)
MODERATORS: Brian E. Lacy, MD, PhD, FACG
10:30 am – 11:30 am
Break – Visit Exhibits
10:30 am – 11:30 am
Exhibitor theater
11:30 am – 12:45 pm
Simultaneous Symposia 1
2:15 pm – 3:00 pm Simultaneous Plenary Sessions
(Exhibit Halls DE)
Samra Sarigol-Blanchard, MD
11. Linaclotide Efficacy on Dyspepsia Symptoms Using Nepean
Dyspepsia Index (NDI) in a Phase 3B Trial of CIC Patients With
Bloating
Anthony Lembo, MD, Nicholas J. Talley, MD, PhD, FACG, Steven
J. Shiff, MD, Bernard J. Lavins, MD, Robyn T. Carson, MPH, Rick
Blakesley, PhD, Xinming Hao, PhD, Mark G. Currie, PhD, Caroline
Kurtz, PhD, Jeffrey M. Johnston, MD, University of Newcastle,
Callaghan, New South Wales, Australia, Forest Laboratories, Jersey
City, NJ, Ironwood Pharmaceuticals, Cambridge, MA
(Exhibit Halls DE)
(Exhibit Halls DE)
simultaneous symposia 1a:Choosing
Biologic Therapy for IBD
and Monitoring
moderator: David T. Rubin, MD, FACG
12. Analysis of Exhaled Volatile Organic Compounds Reveals
New Biomarkers for Irritable Bowel Syndrome
Sophia A. Patel, MD, Nishaben Patel, MD, Vera Okwu, MD, Ammar
Matloob, MD, David Grove, PhD, Ellen Rome, MD, Raed Dweik,
MD, Naim Alkhouri, MD, Pediatric GI, Cleveland Clinic Children’s,
Cleveland, OH; Cleveland Clinic Respiratory Institute, Cleveland,
OH; Cleveland Clinic Pediatric Department, Cleveland, OH
Positioning Biologics in Ulcerative Colitis
Bruce E. Sands, MD, FACG
Describe how timing and selection factor into the implementation of biologic
therapy for UC.
Positioning Biologics in Crohn’s Disease
David T. Rubin, MD, FACG
Describe how timing and selection factor into the implementation of biologic
therapy for Crohn’s disease.
13. Urgency as a Measure of Treatment Effect Due to
Eluxadoline
Anthony Lembo, MD, David Andrae, MD, Scott Dove, MD, Paul
Covington, MD, Beth Israel Deaconess Medical Center, Boston,
MA, Furiex Pharmaceuticals, Morrisville, NC
Appropriate Use and Interpretation of Drug Levels
Marla C. Dubinsky, MD
Incorporate a rational approach to therapeutic drug monitoring in IBD.
Apply recent phase 3 treatment options for genotype 1 infected individuals
who are treatment naïve and non-responders to previous therapy.
14. Plecanatide, a Novel Uroguanylin Analog: A 12-week, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial
to Evaluate Efficacy and Safety in Patients With Irritable Bowel
Syndrome With Constipation (IBS-C)
Philip B. Miner, MD, FACG, Robert DeLuca, MD, Marianela D. La
Portilla, MD, Eveline Padila, MD, William Koltun, MD, Othon H.
Wiltz, MD, Kunwar Shailubhai, PhD, MBA, Gary S. Jacob, PhD,
Patrick Griffin, MD, Laura M. Barrow, PharmD, R&D, Synergy
Pharmaceuticals, Inc., Doylestown, PA, Genoma Research Group,
Miami, FL, Columbus Clinical Services, Miami, FL, Medical Center
for Clinical Research, San Diego, CA, Oklahoma Center for Clinical
Research, Oklahoma City, OK, Medical Research Unlimited, Hialeah, FL, South Medical Research Center, Miami, FL
Genotype 2/3 Other Populations
Andrew J. Muir, MD, MHS
Plenary Session 2: IBD
simultaneous symposia 1b: Hepatitis
Arrived
C: The Future Has
moderator: Stanley M. Cohen, MD
Evaluating Your Patient for Therapy Using All Oral Therapies
Stanley M. Cohen, MD
Use elastography to identify patients with hepatitis C (including fibrosis
assessment).
Genotype 1 Treatment Options
Mitchell L. Shiffman, MD, FACG
Apply treatment options for genotype 2/3 infected individuals including nonresponding genotype 3 cirrhotic patients, implement treatment strategies in
special populations including those who are (a) HCV/HIV infected and (b)
awaiting liver transplant, and explain post-transplant outcomes.
12:45 pm – 1:30 pm Exhibitor Theater
12:45 pm – 2:15 pm Lunch Break – vISIT EXHIBITS
12:45 pm – 2:15 pm Poster Session
1:45 pm – 2:15 pm exhibitor theater
MODERATORS: Uma Mahadevan, MD, FACG
Sunanda V. Kane, MD, MSPH, FACG
15. Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids: A Systematic Review and Meta-Analysis
Neeraj Narula, MD, John K. Marshall, MD, Jean-Frederic
Colombel, MD, PhD, Grigorios I. Leontiadis, MD, Zack Muqtadir,
MD, Walter Reinisch, MD, PhD, Mount Sinai Hospital, New York,
NY, McMaster University, Hamilton, Ontario, Canada
(Exhibit Halls DE)
(Exhibit Halls DE)
(Exhibit Halls DE)
(Exhibit Halls DE)
26
16. Safety of Vedolizumab Alone or With Concomitant
Corticosteroids and/or Immunosuppressants in Patients With
Ulcerative Colitis or Crohn’s Disease
Edward V. Loftus, MD, FACG, Jean-Frederic Colombel, MD,
PhD, Corey A. Siegel, MD, James D. Lewis, MD, FACG, Brihad
Abhyankar, MBA, Serap Sankoh, PhD, Michael Smyth, MBA,
Catherine Milch, MD, Mayo Clinic, Rochester, MN, Icahn School
of Medicine at Mount Sinai, New York, NY, Dartmouth-Hitchcock
Medical Center, Lebanon, NH, Perelman School of Medicine at
the University of Pennsylvania, Philadelphia, PA, Takeda Global
Research and Development Centre (Europe) Ltd., London, U.K.,
Takeda Pharmaceuticals International Co., Cambridge, MA
4:45 pm – 6:00 pm simultaneous symposia 2a:Clearing
moderator: Santhi Swaroop Vege, MD, FACG
Changing Outcomes in Acute Pancreatitis
Santhi Swaroop Vege, MD, FACG
Identify the management options in acute pancreatitis which improve
patient outcomes.
Painful Chronic Pancreatitis: Scope or Knife
Timothy B. Gardner, MD, MS, FACG
Differentiate between the endoscopic or surgical management of chronic
pancreatitis.
Evaluation and Management of Pancreatic Cysts
William R. Brugge, MD, FACG
Determine the most appropriate treatment and management strategies for
pancreatic cysts.
simultaneous symposia 2b:Deciphering IBS:
Understanding the Diverse Pathophysiology
moderator: William D. Chey, MD, FACG
Food Allergies and Food Sensitivities in IBS
Sheila E. Crowe, MD, FACG
18. Post-Operative Mortality for the Inflammatory Bowel
Diseases: A Systematic Review and Meta-Analysis of
Population-Based Studies
Sundeep Singh, MD, Ahmed Al-Darmaki, MD, Alexandra Frolkis,
PhD, Cynthia H. Seow, MD, Yvette P. Leung, MD, Kerri L. Novak,
MD, Subrata Ghosh, MD, Remo Panaccione, MD, Gilaad G.
Kaplan, MD, Division of Gastroenterology, University of Calgary,
Calgary, Alberta, Canada, Department of Medicine, University of
Calgary, Calgary, Alberta, Canada
Counsel IBS patients on how foods contribute to the generation of IBS
symptoms.
An Evidence-based Approach to Dietary Treatment of IBS
Brian E. Lacy, MD, PhD, FACG
Perform an evidence-based review of different diets used to treat IBS.
IBS as an Inflammatory Condition
William D. Chey, MD, FACG
Identify new physiologic processes involved in the development of IBS and
discuss potential treatments.
he American Journal of
T
Gastroenterology Lecture
simultaneous symposia 2c:Live from Philly! The 2nd Annual Endoscopy Video Forum
(Terrace Ballroom 3)
Treatment of IBD: Where We Are and
Where We Are Going
Charles N. Bernstein, MD, FACG
Evaluate the latest treatment options for
patients with IBD.
moderators: Seth A. Gross, MD, FACG, David A. Greenwald, MD, FACG,
and Daniel J. Pambianco, MD, FACG
Exhibitor theater
3:45 pm – 4:40 pm Break – Visit Exhibits
3:55 pm – 4:35 pm
ABIM’s Maintenance of
Certification Program (Room 122AB)
Attend this informational session to
understand how the changes to ABIM’s
MOC Program requirements affect you.
(Exhibit Halls DE)
(Exhibit Halls DE)
ANNUAL
MEETING
This Video Forum Symposium will feature the best video
presentations submitted by colleagues from across the U.S. and
around the world. Submitted during ACG’s Call for Abstracts
and peer-reviewed and selected for presentation, the cases will
feature endoscopy techniques, challenging or unique cases,
and cases in the area of GI endoscopy. During the session,
the audience, along with the Moderators, will vote to select the
best video of ACG 2014. Attendees will view videos showcasing
interesting endoscopic findings and techniques encountered in
daily clinical practice.
See page 4 for more information.
3:30 pm – 4:30 pm Up Confusion in Day-to-day Pancreatic Issues
17. Does End-to-End Versus Side-to-Side Anastomosis in
Postoperative Crohn’s Disease Matter? Prospective 2-Year
Evaluation of Postoperative Quality of Life, Health Care
Utilization, and Clinical Activity
Mahesh Gajendran, MD, Claudia Ramos Rivers, MD, Jana G.
Hashash, MD, Miguel D. Regueiro, MD, FACG, Andrew Watson,
MD, Anthony J. Bauer, PhD, Leonard Baidoo, MD, Arthur M.
Barrie, MD, Marc Schwartz, MD, Jason Swoger, MD, MPH,
Michael A. Dunn, MD, David G. Binion, MD, Department of
Medicine, University of Pittsburgh, Pittsburgh, PA, Division of
Gastroenterology, Hepatology and Nutrition, University of Pittsburgh,
Pittsburgh, PA, Division of Colorectal Surgery, University of
Pittsburgh, Pittsburgh, PA
3:00 pm – 3:45 pm Simultaneous Symposia 2
V1. Incarcerated, Retroflexed Endoscope Associated With a
Para-Esophageal Hernia
Yazen Qumsiyeh, BS, Bashar Qumseya, MD, MPH, Michael
Wallace, MD, MPH, FACG, Herbert Wolfsen, MD, FACG, Mayo
Clinic Florida, Jacksonville, FL
27
Annual Scientific Meeting Agenda – Tuesday, October 21
Tuesday, October 21, 2014
V2. Endoscopic Management of High-Grade Dysplastic Barrett’s
With Esophageal Varices
William Palmer, MD, Milena Di Leo, MD, Manol Jovani, MD,
Herbert Wolfsen, MD, FACG, Murli Krishna, MD, Michael Wallace,
MD, MPH, FACG, Mayo Clinic, Jacksonville, FL, Vita-Salute San
Raffaele University, Scientific Institute San Raffaele, Milan, Italy,
Humanitas Research Hospital, Milan, Rozzano, Italy
6:45 am – 6:15 pm
6:00 am – 5:00 pm
6:45 am – 8:15 am
Cost is $60 per person/per session. Separate registration required.
A USB containing all ACG 2014 Breakfast Sessions submissions
will be provided to attendees registered for any Breakfast Session.
See page 124 for registration information.
V3. Endoscopic Full Thickness Resection (EFTR) of a
Subepithelial Tumor With Extensive Muscularis Propria (MP)
Involvement
Stavros Stavropoulos, MD, Rani Modayil, MD, John Allendorf, MD,
Collin Brathwaite, MD, James Grendell, MD, Winthrop University
Hospital, Mineola, New York, NY
breakfast f: Doctor, Do I Have to Take this Medicine
Forever? Escalation and De-escalation of Therapy in
IBD
V4. Percutaneous Endoscopic Debridement and Washout of a
Bilateral, Loculated, Hepatic Abscess: A Minimally Invasive
Approach to a High-Risk Surgical Situation
Ryan Gaffney, DO, Niraj Gusani, MD, MS, Neil Bhayani, MD,
MHS, Karen Krok, MD, Ian Schreibman, MD, Abraham Mathew,
MD, MHES, Matthew Moyer, MD, MS, Penn State Milton S.
Hershey Medical Center and College of Medicine, Hershey, PA
Moderator: Miguel D. Regueiro, MD, FACG
Can You Stop Therapy in the Patient in Deep Remission?
Asher Kornbluth, MD
Adjust therapy for patients’ deep remission.
Approach to the Patient Not in Deep Remission: Treat to Target
Jean-Paul Achkar, MD, FACG
V5. Successful Endoscopic Resection of Stage T1 Intraductal
Biliary Adenocarcinoma
Truptesh Kothari, MD, MS, Christine Granato, MD, Shivangi Kothari, MD, Glen Hintz, MS, Jennifer Lewis, MD, Asad Ullah, MD,
Ashok Shah, MD, Vivek Kaul, MD, FACG, University of Rochester
Medical Center, Rochester, NY, G. Hintz, Rochester Institute of
Technology, Rochester, NY
Describe the concept of treat-to-target and its current application to
practice.
Continuing Therapy in the Patient With Infection or Malignancy
Miguel D. Regueiro, MD, FACG
Justify the use of biologics during a treatment complication and identify
when to stop immunosuppression.
V6. Endoscopic Therapy Using Self-Expandable Metal Stents
for Walled-Off Pancreatic Necrosis
Susana Lopes, MD, Filipe Vilas-Boas, MD, Pedro Pereira, MD,
Armando Ribeiro, MD, Guilherme Macedo, MD, PhD, Centro Hospitalar S. João, Porto, Portugal
breakfast g: Using
Practice
New ACG Guidelines in Clinical
Moderator: John E. Pandolfino, MD, FACG
Esophageal Eosinophilia and EoE: Are They Different?
Evan S. Dellon, MD
V7. Endoscopic Mucosal Resection of a Diverticular Polyp
Raul Badillo, MD, Michael Wallace, MD, MPH, FACG, Mayo
Clinic, Jacksonville, FL
Describe the new ACG clinical guidelines for EoE and esophageal
eosinophilia.
V8. Endoscopic Retrograde Appendicitis Therapy (ERAT): A New Endoscopic Technique From China
Jitao Song, MD, Bing-Rong Liu, MD, PhD, The Second Affiliated
Hospital of Harbin Medical University, Harbin, China
6:00 pm – 6:30 pm Registration (Broad Street Atrium)
GERD: PPIs and Is There a Dark Side?
Marcelo F. Vela, MD, MSCR, FACG
Explain the new ACG clinical guidelines for GERD.
Achalasia: Diagnosis and Optimization of Treatment
John E. Pandolfino, MD, FACG
Annual Business Meeting Discuss the new ACG clinical guidelines for achalasia.
College Members and Fellows invited.
breakfast h: Common
(Yet Controversial) Topics in
Pancreaticobiliary Disease
Moderator: Douglas G. Adler, MD, FACG
SOD: Does it Exist?
Martin L. Freeman, MD, FACG
Explain the latest evidence characterizing sphincter of Oddi dysfunction.
Gallbladder Polyps: What to Do?
Jason D. Conway, MD
Judge when to resect, when to follow and when to ignore.
Large Stones Made Easy
Douglas G. Adler, MD, FACG
Discuss the techniques to be used alone and in combination to remove
large stones.
28
breakfast i:
breakfast l:
Functional Anorectal Disease: Do Ask
Fatty Liver Diseases: You Can’t Escape
and Do Tell
Them
Moderator: Amy E. Foxx-Orenstein, DO, FACG
Moderator: Mary E. Rinella, MD, FACG
Urgency, Tenesmus and Leakage: How Can I Help?
Satish S. C. Rao, MD, PhD, FACG
Non-Alcoholic Fatty Liver Disease: What Is Beyond Vitamin E?
Mary E. Rinella, MD, FACG
Evaluate patients with non-alcoholic fatty liver disease and identify
which patients require a liver biopsy and which can be followed.
Discuss current therapies available and those in the pipeline.
Explain the physiology of the pelvic floor and identify risk factors for
tenesmus, urgency and fecal soiling.
Medical, Endoscopic and Surgical Treatments for Incontinence
Michael D. Brown, MD, FACG
One Bourbon, One Scotch and One Beer: What to Do When They Are
Drinking
Vijay H. Shah, MD, FACG
Discuss evidence-based therapies for the treatment of fecal incontinence.
Pelvic Floor Dysfunction: How to Diagnose and How to Treat
Amy E. Foxx-Orenstein, DO, FACG
Classify clinical spectrum of alcoholic fatty liver disease, who requires
therapy and with what, and how to apply the Lille criteria in treatment of
alcoholic hepatitis.
Identify the patient with pelvic floor dysfunction and construct an
individualized treatment program.
Recognizing and Preventing Drug-induced Liver Injury in Those With
Chronic Liver Disease, Including Those With Fatty Liver
Victor J. Navarro, MD
breakfast j:
Pushing the Envelope With New
Endoscopic Techniques
Discuss the latest techniques and devices for closing luminal perforations.
Identify the different types of drug-induced liver disease, explain how
those with non-alcoholic fatty liver disease, in general, are not at higher
risk of drug-induced liver injury, determine how much acetaminophen can
be administered and which populations require caution, and plan how
to approach patients with chronic liver disease who require potentially
hepatotoxic medicines.
Want to Lose Weight? The Endoscopic Options
Richard I. Rothstein, MD, FACG
breakfast m: Medicolegal
Moderator: Richard I. Rothstein, MD, FACG
Perforation: We Can Fix That!
Louis-Michel Wong Kee Song, MD
Describe endoscopic management of obesity.
Issues in Gastroenterology
Moderator: Richard S. Bloomfeld, MD, FACG
Endoscopic Treatment of Hemorrhoids
Waqar A. Qureshi, MD, FACG
Why Are Gastroenterologists Sued?
Richard S. Bloomfeld, MD, FACG
Identify new endoscopic therapies for hemorrhoid treatment.
Identify top reasons gastroenterologists are named in lawsuits.
Documentation and Communication Tips to Prevent Lawsuits
John Baillie, MB, ChB, FACG
breakfast k: The
Gastroenterologist and the Pregnant Patient
Moderator: Sunanda V. Kane, MD, MSPH, FACG
Describe ways to improve documentation and communication to modify
your risk of adverse medicolegal events.
GI Meds in Pregnancy
Sunanda V. Kane, MD, MSPH, FACG
Refusing and Dismissing Problem Patients
Andrew D. Feld, MD, JD, FACG
Identify available pharmacological therapies that are safe for treatment of GI
disorders in the pregnant patient.
Establish policies for handling challenging patients in your practice.
IBD and Pregnancy
Sonia Friedman, MD, FACG
6:00 am – 5:00 pm
8:30 am – 6:15 pm
Scientific Meeting
8:30 am – 10:00 am SIMULTANEOUS Plenary SessionS
Define strategies for a successful pregnancy outcome in the IBD patient,
including fertility, preparation of the patient for pregnancy, monitoring and
postpartum issues.
Plenary Session 1: Endoscopy / Colorectal Cancer Prevention
MODERATORS: Mark B. Pochapin, MD, FACG
Evaluate diagnostic and management options for liver diseases in
pregnancy.
David A. Johnson, MD, MACG
19. A Phase IIb Study Comparing the Safety and Efficacy of
Remimazolam and Midazolam in Colonoscopy Patients
Daniel J. Pambianco, MD, FACG, Keith Borkett, BSc, Dennis
Riff, MD, Peter Winkle, MD, Howard Schwartz, MD, Timothy
Melson, MD, Karin Wilhelm-Ogunbiyi, MD, Charlottesville Medical Research, Charlottesville, VA, Paion UK Ltd., Cambridge,
United Kingdom, Anaheim Clinical Trials, Anaheim, CA, Miami
Research Institute, Miami, FL, Helen Keller Hospital, Sheffield,
AL, PAION Deutschland GmbH, Anchen, Germany
29
ANNUAL
MEETING
Liver Disease in Pregnancy
Tram T. Tran, MD
20. What Is the Optimum Time to Do Endoscopy in Acute
Caustic Ingestion?
Munish Ashat, MD, Pradeep K. Siddappa, DM, Saroj K. Sinha,
DM, Usha Dutta, DM, Rakesh Kochhar, DM, Gastroenterology,
Post Graduate Institute of Medical Education and Research,
Panchkula, Haryana, India
sity School of Medicine, New Orleans, LA; Louisiana Tumor Registry, School of Public Health, Louisiana State University Health
Sciences Center, New Orleans, LA
27B. Population-Based Lynch Syndrome (LS) Screening in
Colorectal Cancer (CRC) Patients Aged ≤50 Years: A Statewide
Analysis of Timing of Microsatellite Instability (MSI) Test
Result Availability in Relation to Surgery
2014 ACG Governors Award for Excellence in Clinical Research
Jordan J. Karlitz, MD, Mei-chin Hsieh, MSPH, Yong Liu, BS,
Christine Blanton, MD, Beth Schmidt, MD, Meredith Sherrill, MD,
Sanjay Sikka, MD, Giuseppe Gagliardi, MD, Xiao-Cheng Wu, MD,
MPH, Vivien W. Chen, PhD, MD, Medicine, Tulane University
School of Medicine, New Orleans, LA, Louisiana Tumor Registry,
School of Public Health, Louisiana State University Health
Sciences Center, New Orleans, LA
21. Volumetric Laser Endomicroscopy in Barrett’s Esophagus
– Feasibility of Use and Detection of Dysplasia in Clinical
Practice
Jeffrey Mosko, MD, FRCPC, Sumeet K. Tewani, MD, Ivana
Dzeletovic, MD, Gyanprakash Ketwaroo, MD, Tyler Berzin, MD,
Ram Chuttani, MD, Mandeep Sawhney, MD, Douglas Pleskow,
MD, Beth Israel Deaconess Medical Center and Harvard Medical
School, Boston, MA
22. Natural Orifice Endoscopic Surgery (NOTES) Techniques
for Full Thickness R0 Endoscopic Resection of Deep Seated
Subepithelial Tumors (SETs): First U.S. Cases
Stavros Stavropoulos, MD, Rani J. Modayil, MD, Collin Brathwaite, MD, Kumkum S. Patel, MD, Thomas Coppola, DO, John
Allendorf, MD, David Friedel, MD, James Grendell, MD, Winthrop
University Hospital, Mineola, NY
Plenary Session 2: Liver
MODERATORS: Kris V. Kowdley, MD, FACG
Paul Y. Kwo, MD, FACG
28. Association Between Aspirin Use and Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study From the Third National Health and Nutrition Examination Survey
Huafeng Shen, MD, Ghulamullah Shahzad, MD, Mahreema
Jawairia, MD, Paul Mustacchia, MD, NUMC, East Meadow, NY
23. Over-The-Scope-Clip and Cap-Assisted Method for the Resection of Submucosal Lesions of the Gastrointestinal Tract:
A Multi-Center Study
Shabnam Sarker, MD, Marcel Sandmann, MD, Martin Faendrich,
MD, Kondal Kyanam Kabir Baig, MD, Klaus Monkemuller, MD,
PhD, Gastroenterology, University of Alabama, Birmingham, AL,
Klinikum Dortmund, Dortmund, Germany
29. Serum Ceruloplasmin, Ferritin, and Their Ratio Are
Significantly Associated with Nonalcoholic Steatohepatitis in
Patients with NAFLD
Danny Issa, MD, Rocio Lopez, MS, Ariel E. Feldstein, MD,
Mohamed Yaseen Alsabbagh, MD, Naim Alkhouri, MD, Cleveland
Clinic, Cleveland, OH
24. Is Cold Biopsy the Best Method for Diminutive Colonic
Polyp Removal? A Systematic Review and Meta-analysis
Dany Raad, MD, Priyam Tripathi, MD, MPH, Gregory Cooper, MD,
FACG, Yngve Falck-Ytter, MD, Case Western Reserve University/
University Hospitals Case Medical Center/VA Medical Center,
Cleveland, OH
30. Mean Platelet Volume, Red Cell Distribution Width to
Platelet Count Index, Globulin Platelet Index and 12 Other
Simple Non-invasive Fibrosis Scores: How Much Do Routine
Blood Tests Tell About Liver Fibrosis?
Ragesh B. Thandassery, MD, DM, Anil John, MD, DM, MRCP,
Madiha Soofi, MD, Syed A. Mohiuddin, MBBS, Mohammed E.
Elbadri, MD, Saad Al Kaabi, MD, Division of Gastroenterology,
Department of Medicine, Hamad Medical Corporation, Doha,
Qatar, Department of Laboratory Medicine and Pathology, Hamad
Medical Corporation, Doha, Qatar
25. Withdrawal Times, Adenoma Detection Rates, and Risk of
Interval Colorectal Cancer
Aasma Shaukat, MD, MPH, FACG, Thomas Rector, PhD, Timothy
R. Church, PhD, Frank Lederle, MD, Adam S. Kim, MD, Jeffrey
Rank, MD, John I. Allen, MD, Minneapolis VA Medical Center,
Minneapolis, MN, University of Minnesota, Minneapolis, MN, Minnesota Gastroenterology, PA, Minneapolis, MN
31. Idiosyncratic Drug-Induced Liver Injury (DILI) in the United
States: A Report of 1,257 Prospectively Enrolled Patients
Naga P. Chalasani, MD, FACG, Herbert Bonkovsky, MD, FACG,
Robert Fontana, MD, William Lee, MD, FACG, Andrew Stolz, MD,
Jay Talwalkar, MD, FACG, Rajender Reddy, MD, FACG, Paul Watkins, MD, Victor Navarro, MD, Huiman Barnhart, PhD, Jiezhun
Gu, PhD, Jose Serrano, MD, Indiana University School of Medicine, Indianapolis, IN, Carolinas Health Care System, Charlotte,
NC, University of Michigan, Ann Arbor, MI, UT-Southwestern, Dallas, TX, University of Southern California, Los Angeles, CA, Mayo
Clinic, Rochester, MN, University of Pennsylvania, Philadelphia,
PA, University of North Carolina, Chapel Hill, NC, Einstein Medical Center, Philadelphia, PA, Duke Clinical Research Institute,
Durham, NC, NIDDK, Bethesda, MD
26. A Phase-3 Placebo-Controlled Trial of Celecoxib in Pediatric Subjects With Familial Adenomatous Polyposis
Carol A. Burke, MD, FACG, Patrick M. Lynch, MD, Robin K. Phillips, MD, Manuela F. Berger, MD, Chunming Li, PhD, Dinu Iorga,
MD, Cleveland Clinic, Cleveland, OH, MD Anderson Cancer Center, Houston, TX, St. Marks Hospital, Middlesex, London, United
Kingdom, Pfizer, Inc., New York, NY
combined abstracts
27A. Statewide, Population-Based Lynch Syndrome (LS)
Screening by Microsatellite Instability (MSI) in Colorectal Cancer (CRC) Patients Aged ≤50 Years: Frequency, Determinants of Testing, and Result Analysis
Jordan J. Karlitz, MD, Mei-chin Hsieh, MSPH, Yong Liu, BS,
Christine Blanton, MD, Beth Schmidt, MSPH, Xiao-Cheng Wu,
MD, MPH, Vivien W. Chen, PhD, MPH, Medicine, Tulane UniverFor more information on ACG 2014 and to register, visit www.acgmeetings.gi.org.
30
32. Health Related Quality of Life (HRQL) and Health Utilities
(HU) of Patients With Chronic Hepatitis C (CH-C) Treated With
an Interferon (IFN)-Free Regimen Containing Ledipasvir (LDV)
and Sofosbuvir (SOF)
Zobair Younossi, MD, MPH, FACG, Maria Stepanova, PhD, Patrick
Marcellin, MD, PhD, Nezam Afdhal, MD, Kris V. Kowdley, MD,
FACG, Stefan Zeuzem, MD, Linda Henry, PhD, Sharon Hunt,
MBA, Center for Liver Diseases, Department of Medicine, Inova
Fairfax Hospital, Falls Church, VA; CLDQ LLC, Washington, DC,
Viral Hepatitis Research Unit in Hospital Beaujon, Clichy, France,
Beth Israel Deaconess Medical Center, Boston, MA, Digestive
Diseases Institute, Digestive Diseases Institute, Virginia Mason
Clinic, Seattle, WA, Department of Medicine, J.W. Goethe University Hospital, Frankfurt, Germany, Betty and Guy Beatty Center
for Integrated Research, Inova Health System, Falls Church, VA
10:00 am – 4:30 pm
Exhibit Hall Opens
10:00 am – 4:30 pm
Hands-on Workshop Center
33. Management of Hemoglobin Decrease in Patients Treated
With ABT-450/Ritonavir/Ombitasvir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients
Vinod Rustgi, MD, FACG, David Bernstein, MD, FACG, Thomas
Sepe, MD, FACG, William King, MD, Moises Diago, MD, Pietro
Andreone, MD, Daniel Forton, PhD, Hendrik Reesink, MD, Peter
Ferenci, MD, Yiran Hu, MS, Jeffrey Enejosa, MD, Daniel Cohen, MD, Yan Luo, MD, PhD, Marcos Pedrosa, MD, PhD, John
Vierling, MD, Metropolitan Research, Fairfax, VA, North Shore
University Hospital (BRANY), Manhasset, NY, University Gastroenterology, Providence, RI, Trial Management Associates, LLC,
Wilmington, NC, Hospital Quirón de Valencia, Unidad de Hepatología, Servicio de Aparato Digestivo, Valencia, Spain, Department of Medical and Surgical Sciences, University of Bologna,
Bologna, Italy, St. George’s, University of London, London, United
Kingdom, Academisch Medisch Centrum, Universiteit van Amsterdam, Gastroenterology & Hepatology, Amsterdam, Netherlands,
Department of Internal Medicine 3, Medical University of Vienna,
Vienna, Austria, AbbVie Inc., North Chicago, IL, Advanced Liver
Therapies, Baylor St. Luke’s Medical Center, Houston, TX
moderator: Douglas K. Rex, MD, MACG
(Exhibit Halls DE)
10:30 am – 11:30 am Break – Visit Exhibits
(Exhibit Halls DE)
10:30 am – 11:30 am Exhibitor theater
(Exhibit Halls DE)
11:30 am – 12:45 pm Simultaneous Symposia 3
simultaneous symposia 3a:Quality
Here and Now
in Colonoscopy: Quality Indicators in Colonoscopy and How to Improve Them in
Practice
Aasma Shaukat, MD, MPH, FACG
Define current quality indicators and discuss technology and techniques
to improve them in practice.
Detection and Resection of Serrated Polyps
Douglas K. Rex, MD, MACG
Determine the classification, pathology variation and methods to improve
detection and resection of serrated polyps.
Controversies in Surveillance Guidelines
Dennis J. Ahnen, MD
Analyze surveillance guidelines for serrated polyps and other grey areas.
simultaneous symposia 3b:Reading Between the Lines:
The Refractory Esophageal Patient – What the
Guidelines Do Not Address
moderator: Evan S. Dellon, MD, MPH
34. Sex, Age and Race Are Associated With Increased Risk of
Exposure to Hepatitis E in the U.S.
Tyler B. Fleming, MD, Alla Y. Grigorian, MD, PhD, Bilal Aslam,
MS, IV, Philip Westgate, PhD, Houssam E. Mardini, MD, MPH,
University of Kentucky College of Medicine, Lexington, KY, University of Kentucky College of Public Health, Lexington, KY
Achalasia: New Treatment Paradigms
Steven R. DeMeester, MD, FACG
Describe new treatments, including POEM, as well as patient selection for
surgical therapy and management of post-surgical complications.
EoE: When Steroids Fail
Evan S. Dellon, MD, MPH
35. The Impact of Hyponatremia on the Outcomes of Wait-Listed and Transplanted Patients With Liver Cirrhosis
Mohammed Eyad Yaseen Alsabbagh, MD, Bayan Alsuleiman, MD,
Naim Alkhouri, MD, Cleveland Clinic, Cleveland, OH
Discuss the reasons and treatment approaches for steroid-refractory EoE
patients, including dietary elimination and dilation.
Refractory GERD: What Are the Options in 2014?
Ronnie Fass, MD, FACG
36. Reserved for Late Breaking Abstract
Describe current treatment options for PPI-refractory GERD, optimal
selection of patients for surgery and post-op complications/recurrences.
J. Edward Berk Distinguished Lecture (Terrace Ballroom 3)
GI and Endoscopic Training for the Future Gastroenterologist
Richard A. Kozarek, MD, FACG
Identify the fundamentals of GI and
endoscopic training for tomorrow’s GI.
Introduced by:
ACG President
12:45 pm – 2:15 pm Lunch Break
(Exhibit Halls DE)
12:45 pm – 2:15 pm ANNUAL
MEETING
10:00 am – 10:30 am (Exhibit Halls DE)
Poster Session
(Exhibit Halls DE)
12:45 pm – 1:15 pm Exhibitor theater
(Exhibit Halls DE)
1:45 pm – 2:15 pm Exhibitor theater
(Exhibit Halls DE)
31
2:15 pm – 3:45 pm Simultaneous Plenary Sessions
42. Improvement in Symptoms and QOL Is Sustained With Minimal Side Effects 4 Years After Magnetic Sphincter
Augmentation (LINX) for GERD
Philip O. Katz, MD, FACG, Kenneth R. DeVault, MD, FACG, Steven A. Edmundowicz, MD, Steven C. Schlack-Haerer, MD, Robert
A. Ganz, MD, Einstein Medical Center, Philadelphia, PA, Mayo
Clinic Florida, Jacksonville, FL, Washington University School of
Medicine, St. Louis, MO, Gundersen Health System, La Crosse,
Wisconsin, Minnesota Gastroenterology, Minneapolis, MN
Plenary Session 1: Esophagus
MODERATORS: Nicholas J. Shaheen, MD, MPH, FACG
Marcelo F. Vela, MD, FACG
37. Efficacy of Topical Corticosteroids in the Treatment of
Eosinophilic Esophagitis: A Meta-Analysis and Systematic
Review of Placebo Controlled Randomized Clinical Trials
Ashutosh Gupta, MD, Venkatesh Ravi, MD, Arvind R. Murali, MD,
Bashar M. Attar, MD, PhD, FACG, Pramoda Koduru, MD, John H.
Stroger Hospital of Cook County, Chicago, IL
38. Site Volume Is Inversely Associated With Recurrence Rate
After Successful Radiofrequency Ablation (RFA): An Analysis of
the U.S. RFA Registry
Cary C. Cotton, BA, W. Asher Wolf, MD, MPH, Srinadh Komanduri, MD, MS, Charles J. Lightdale, MD, MACG, Anthony Infantolino, MD, FACG, Herbert C. Wolfsen, MD, FACG, Nicholas J.
Shaheen, MD, MPH, FACG, University of North Carolina, Center
for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Chapel Hill, NC, Northwestern University
Feinberg School of Medicine, Chicago, IL, Columbia University
Department of Medicine, New York, NY, Jefferson Medical College,
Philadelphia, PA, Mayo Clinic Florida, Jacksonville, FL
39. DNA Methylation Changes in Barrett’s Epithelium and Adjacent Normal Mucosa
Tamas A. Gonda, MD, Samuel Stevens, BA, Clare LaFave, PhD,
Charles J. Lightdale, MD, MACG, Benjamin Tycko, MD, PhD, Gastroenterology, Columbia University Medical Center, New York, NY
Plenary Session 2: Pancreatic / Biliary
MODERATORS: Linda S. Lee, MD
Scott M. Tenner, MD, MPH, JD, FACG
46. Rapid Point-of-Care Measurement of Cyst Fluid Glucose Is
Feasible and Accurate in Predicting Mucinous Pancreatic Cysts
Thomas Zikos, MD, Kimberly Pham, MS, Ann Chen, MD, Subhas Banerjee, MD, Shai Friedland, MD, MS, Monica Dua, MD,
Jeffrey Norton, MD, George Poultsides, MD, MS, Brenda Visser,
MD, Walter Park, MD, MS, Medicine/Gastroenterology, Stanford
University, Stanford, CA
47. RNA Sequencing of Cystic Lesions of the Pancreas
Sarah Rodriguez, MD, Terry Morgan, PhD, Brintha K. Enestvedt,
MD, Carl Pelz, Gene Bakis, MD, Soren Impey, PhD, Gastroenterology, The Oregon Clinic-West, Portland, OR, Oregon Health and
Science University, Portland, OR
40. Endoscopic Radiofrequency Energy Delivery to the Lower
Esophageal Sphincter for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
Seth Lipka, MD, Ambuj Kumar, MD, MPH, Joel E. Richter, MD,
MACG, Digestive Diseases and Nutrition, University of South
Florida, Morsani College of Medicine, Tampa, FL, Division of
Evidence Based Medicine and Outcomes Research, University of
South Florida, Morsani College of Medicine, Tampa, FL, Department of Digestive Diseases and Nutrition, University of South FL,
Morsani College of Medicine, Joy McCann Culverhouse Center for
Swallowing Disorders, Tampa, FL
48. Risk Factors for Malignant Progression of Intraductal Papillary Mucinous Neoplasms (IPMN): An International Registry
Cohort
Maria Moris Felgueroso, MD, Michael B. Wallace, MD, FACG,
Massimo Raimondo, MD, FACG, Timothy A. Woodward, MD,
Verna J. Skinner, MD, Paolo G. Arcidiacono, MD, Cinzia Boemo,
MD, Maria C. Petrone, MD, Claudio De Angelis, MD, Selene F.
Manfre, MD, Pietro Fusaroli, MD, Michele Lewis, MD, Mayo Clinic
Jacksonville, Jacksonville, FL, San Raffaele Scientific Institute,
Milan, Italy, University of Turin, Turin, Italy, Ospedale di Castel
San Pietro Terme, Bologna, Italy
41. Transoral Fundoplication Provides Better GERD Symptom
Control Than PPIs in Patients With Troublesome Regurgitation:
A Multicenter Sham-Controlled Randomized Clinical Trial
Peter J. Kahrilas, MD, FACG, John Hunter, MD, Reginald Bell,
MD, Erik Wilson, MD, Karim Trad, MD, James Dolan, MD, Kyle
Perry, MD, Brant Oelschlager, MD, Nathaniel Soper, MD, Miguel
Burch, MD, W. Scott Melvin, MD, Kevin Reavis, MD, Daniel Turgeon, MD, Eric Hungness, MD, Brian Diggs, PhD, Brad Snyder,
MD, Medicine, Northwestern University, Chicago, IL, Oregon
Health & Science University, Portland, OR, SurgOne Foregut Institute, Englewood, CO, University of Texas Health & Science Center,
Houston, TX, The George Washington University of Medicine and
Health Sciences, Washington, DC, Reston Surgical Associates,
Reston, VA, The Ohio State University, Columbus, OH, University
of Washington, Seattle, WA, Cedars-Sinai Medical Center, Los
Angeles, CA, Oregon Clinic, Portland, OR
49. Morbid Obesity (MO) Is Associated With Increased Healthcare Utilization and Is an Independent Predictor of Mortality of
Acute Pancreatitis (AP)
Somashekar G. Krishna, MD, MPH, Samer El-Dika, MD, Alice
Hinton, PhD, Jeffrey R. Groce, MD, Hisham Hussan, MD, Cheng
Zhang, MD, PhD, Peter P. Stanich, MD, Na Li, MD, Darwin L.
Conwell, MD, MS, Department of Gastroenterology, Hepatology
and Nutrition, The Ohio State University Medical Center, Columbus, OH
32
50. Acute Pancreatitis (AP) in Post-Bariatric Surgery (BRS)
Status: Analysis of National Trends, Complications and
Outcomes from 2007 to 2011
2014 ACG Obesity Award
Somashekar G. Krishna, MD, MPH, Jennifer Behzadi, MD,
Alice Hinton, PhD, Samer El-Dika, MD, Jeffrey R. Groce, MD,
Hisham Hussan, MD, Darwin L. Conwell, MD, MS, Department
of Gastroenterology, Hepatology and Nutrition, The Ohio State
University Medical Center, Columbus, OH
5:00 pm – 6:15 pm Simultaneous Symposia 4
simultaneous symposia 4a:Obesity:
The Hunger Games
moderator: Steven A. Edmundowicz, MD
Which Surgery Will Keep Your BMI in Check?
Alfons Pomp, MD
Compare the different surgical options in the management of obesity.
Post-operative Complications: Metabolic and Nutritional
John K. DiBaise, MD, FACG
51. Prevalence of Exocrine and Endocrine Pancreatic
Insufficiency After Sentinel Acute Pancreatitis (AP)
Kishore Vipperla, MD, Georgios Papachristou, MD, Adam Slivka,
MD, PhD, David Whitcomb, MD, PhD, Dhiraj Yadav, MD, MPH,
University of Pittsburgh Medical Center, Pittsburgh, PA
Identify and manage the potential metabolic complications post-bariatric
surgery.
Post-operative Complications: Endoscopic Management
Steven A. Edmundowicz, MD
Define how to endoscopically manage post-bariatric surgical complications.
simultaneous symposia 4b:Pearls and Pitfalls of Routine
IBD Management: Case Studies
3:45 pm – 4:30 pm Break – Visit Exhibits
moderator: Uma Mahadevan, MD, FACG
(Exhibit Halls DE)
The Newly Diagnosed IBD Patient
Edward V. Loftus, Jr., MD, FACG
4:30 pm – 5:00 pm Emily Couric Memorial Lecture
Apply appropriate initial therapy for newly diagnosed IBD patients.
Cancer in IBD: The Colon and Beyond
Describe the role of surveillance techniques to
prevent colon cancer in IBD, and identify the
risks of medication-related malignancies in IBD.
The Medically Refractory IBD Patient
Uma Mahadevan, MD, FACG
Apply a comprehensive approach to the patient with refractory symptoms.
The Post-operative Patient
Miguel D. Regueiro, MD, FACG
Sponsored by the ACG, the Virginia Gastroenterological Society and the Old Dominion Society of
Gastroenterology Nurses and Associates
Apply a therapy for the prevention of recurrence.
6:15 pm Introduced by:
ACG President
ADJOURN
ANNUAL
MEETING
33
Annual Scientific Meeting Agenda – Wednesday, October 22
Wednesday, October 22, 2014
breakfast p: Beyond the Burn: Controversies in
Barrett's Esophagus
6:45 am – 12:15 pm
6:00 am – 12:15 pm
Moderator: Nicholas J. Shaheen, MD, MPH, FACG
Difficult Ablation: When to Step on the Pedal and When to
Refer
Kenneth K. Wang, MD, FACG
Discuss cases that present difficulty for ablation such as
nodularity, long segment BE, large hiatal hernias and esophageal
varices, and determine when they can be safely performed and
when a referral is needed.
6:45 am – 8:15 am
Cost is $60 per person/per session. Separate registration required. A USB containing all ACG 2014 Breakfast Sessions submissions will be provided to attendees registered for any Breakfast Session. See page 124 for registration information.
breakfast n: Common
Liver Outpatient Consults
Afterburn: Surveillance After Ablation and Management of
Recurrence
Nicholas J. Shaheen, MD, MPH, FACG
Moderator: Santiago J. Munoz, MD, FACG
The Patient With a Solid Liver Mass
K. Rajender Reddy, MD, FACG
Explain post-ablation surveillance protocols and the strategy for treating BE
recurrence after ablation.
Distinguish between benign and malignant liver masses on imaging, and
develop strategies to screen for hepatoma in patients with advanced
fibrosis.
Esophagectomy in 2014: What Is the Role?
Steven R. DeMeester, MD, FACG
Describe the circumstance in which esophagectomy for BE is still indicated,
and differences between the U.S. and British guidelines.
The Abnormal Liver Panel
Santiago J. Munoz, MD, FACG
Evaluate abnormal liver tests and identify the presence or absence of
advanced liver disease.
breakfast q: Thinking Outside the Bowel: Common
Complications of IBD and IBD Therapy
The Hepatitis B Infected Patient
Joseph K. Lim, MD, FACG
Moderator: Jason M. Swoger, MD, MPH
Interpret hepatitis B serologies to determine whether to follow or treat the
infected patient.
breakfast o: Practical
Skin
Jason M. Swoger, MD, MPH
Identify common skin manifestations of IBD and complications from
therapy.
Colonoscopy
Moderator: Joseph C. Anderson, MD
Arthralgias
Christina Y. Ha, MD
What’s New in Colonoscopy Prep
Brooks D. Cash, MD, FACG
Discuss recent data regarding various prep regimens, qualities,
and adjunctive measures to achieve an optimal bowel prep.
Differentiate the causes and identify treatment of joint pain in the patient
with IBD.
Abnormal Liver Function Tests
Paul Martin, MD, FACG
The Incomplete Colonoscopy: What Next?
Jonathan A. Leighton, MD, FACG
Outline common liver complications of IBD and IBD therapy.
Explain the options for patients who have an incomplete colonoscopy.
Approach to the Difficult Polypectomy
Charles J. Kahi, MD, FACG
Identify techniques for successful and complete polyp resection.
34
6:00 am – 12:15 pm Registration (Broad Street Atrium)
8:30 am – 12:15 pm
Scientific Meeting
8:30 am – 10:15 am Simultaneous Plenary Sessions
61. Association of Mean Vitamin D Level With Clinical Status
in Inflammatory Bowel Disease: A 5 Year Prospective Study
Toufic A. Kabbani, MD, MPH, Claudia Ramos Rivers, MD, Jason
Swoger, MD, MPH, Miguel D. Regueiro, MD, FACG, Arthur M.
Barrie, MD, PhD, Marc Schwartz, MD, Jana G. Hashash, MD,
Leonard Baidoo, MD, FACG, Michael A. Dunn, MD, David G. Binion, MD, University of Pittsburgh Medical Center, Pittsburgh, PA
Plenary Session 1: IBD / Small Intestine / Unclassified
MODERATORS: Francis A. Farraye, MD, MSc, FACG
Jonathan A. Leighton MD, FACG
62. Health Outcomes of Ulcerative Colitis (UC) and Crohn’s Disease (CD) Patients Hospitalized With Human Cytomegalovirus (CMV) Disease
Cheng Zhang, MD, Edward J. Levine, MD, Somashekar G.
Krishna, MD, Alice Hinton, PhD, Darwin L. Conwell, MD, Razvan
Arsenescu, MD, Inflammatory Bowel Disease Program, Division of
Gastroenterology, Hepatology, & Nutrition, The Ohio State University, Columbus, OH; Division of Biostatics, College of Public
Health, The Ohio State University, Columbus, OH
55. The Clinical Characteristics of HLA Genotype DQ2.2 in a
U.S. Adult Celiac Disease Population
Richard Wu, MD, MPH, Stephanie Moleski, MD, C. Andrew Kistler, MD, PharmD, Beth Colombe, PhD, Anthony DiMarino, MD,
Thomas Jefferson University Hospital, Philadelphia, PA
56. Impact of Small Bowel Imaging on the Histological Patterns of Small Bowel Tumors: Analysis With SEER Database
2014 ACG Lawlor Resident Award
Felix H. Lui, MD, Richard E. Shaw, PhD, Lauren B. Gerson, MD,
FACG, Internal Medicine, California Pacific Medical Center, San
Francisco, CA; Division of Clinical Informatics, California Pacific
Medical Center, San Francisco, CA; Division of Gastroenterology,
California Pacific Medical Center, San Francisco, CA
63. The Risk of a Second Non-Melanoma Skin Cancer With
Thiopurine and Anti-TNF Use in Inflammatory Bowel Disease
Frank I. Scott, MD, MSCE, Ronac Mamtani, MD, MSCE, Colleen Brensinger, MS, Kevin Haynes, PharmD, MSCE, Zelma C.
Chiesa-Fuxench, MD, Jie Zhang, PhD, Lang Chen, MD, PhD,
Fenglong Xie, MS, David J. Margolis, MD, PhD, Jeffrey R. Curtis,
MD, MS, MPH, James D. Lewis, MD, MSCE, Abramson Cancer
Center, Perelman School of Medicine, University of Pennsylvania,
Philadelphia, PA, Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL,
Division of Clinical Immunology and Rheumatology, University of
Alabama at Birmingham, Birmingham, AL, Department of Dermatology, Perelman School of Medicine, University of Pennsylvania,
Philadelphia, PA, Division of Gastroenterology, Perelman School
of Medicine, University of Pennsylvania, Philadelphia, PA, Center
for Clinical Epidemiology and Biostatistics, Perelman School of
Medicine, University of Pennsylvania, Philadelph, PA
57. Small Bowel Cancer in the U.K.
Lolita Chan, BSc, MBChB, MCRP, Gareth Evans, MBBS, MRCP,
MD, FRCP, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom
58. Mode of Childbirth and Long-term Outcomes in Women
With Inflammatory Bowel Diseases
Ashwin N. Ananthakrishnan, MD, MPH, Andrew Cagan, BS, Vivian Gainer, MS, Tianxi Cai, PhD, Stanley Shaw, MD, PhD, Susanne
Churchill, PhD, Elizabeth Karlsin, MD, MPH, Shawn Murphy,
MD, PhD, Isaac Kohane, MD, PhD, Katherine Liao, MD, MPH,
Gastrointestinal Unit, Massachusetts General Hospital, Boston,
MA; Harvard School of Public Health, Boston, MA, Brigham and
Women’s Hospital, Boston, MA, Partners Healthcare, Boston, MA
Plenary Session 2: Stomach / Colon
MODERATORS: Joseph C. Anderson, MD
Francisco C. Ramirez, MD, FACG
59. Updated Incidence and Prevalence of Crohn’s Disease and
Ulcerative Colitis in Olmsted County, Minnesota (between 1970
and 2010)
2014 ACG IBD Research Award
Raina Shivashankar, MD, William J. Tremaine, MD, FACG, Scott
W. Harmsen, MS, Alan Zinsmeister, PhD, Edward V. Loftus, MD,
FACG, Gastroenterology and Hepatology, Mayo Clinic, Rochester,
MN
64. Risks of Thromboembolism Versus Recurrent GI
Hemorrhage After Interruption of Anticoagulation in Admitted
Patients With GI Bleeding (GIB) – A Prospective Study
Neil Sengupta, MD, Joseph Feuerstein, MD, Vilas R. Patwardhan,
MD, Gyanprakash Ketwaroo, MD, Adarsh M. Thaker, MD, Daniel
Leffler, MD, Beth Israel Deaconess Medical Center, Boston, MA
35
ANNUAL
MEETING
65. Topographical Mapping in a Cohort of Patients With
Gastric Intestinal Metaplasia
Manish B. Singla, MD, Steven Armbruster, MD, Nisha Shah,
MD, Molly Burman, BSN, Corinne L. Maydonovitch, BS, Patrick
E. Young, MD, FACG, Jayde Kurland, MD, FACG, Scott Itzkowitz, DO, FACG, Walter Reed National Military Medical Center,
Washington, DC, Gastrointestinal Associates, Lima, OH
60. Impact of Immigration on Phenotype and Severity of
Inflammatory Bowel Disease: A Prospective Cohort Study of
Hispanics in the United States
2014 ACG IBD Research Award
Nirupama Bonthala, MD, Jared Macklin, MD, Syeda Hamadani,
MD, Mark Salem, MD, Rachel Demisse, MD, Beverly Chen, MD,
Caroline Hwang, MD, Gastroenterolgy and Hepatology, University
of Southern California, Los Angeles, CA
66. An Assessment of Gastric and Small Bowel Pressure
Profiles in Diabetics With Gastroparesis Before and During 28
Days of Treatment With the Motilin Receptor Agonist Camicinal
(GSK962040)
Kenneth Barshop, MD, George Dukes, MD, Matthew Barton, MD,
Jack Semler, MD, Braden Kuo, MD, University of Chicago Pritzker
School of Medicine, Chicago, IL, Massachusetts General Hospital,
Boston, MA, GlaxoSmithKline, Raleigh, NC
10:15 am – 10:45 am (Terrace Ballroom 3)
Idiosyncratic Drug-Induced Liver Injury: What Have We Learned in the Last
Decade?
Naga P. Chalasani, MD, FACG
Assess recent developments in the diagnosis
and management of DILI.
Introduced by:
ACG President
67. Gastric Electric Stimulation: A Prospective Analysis of 151
Patients at a Single Center
Jason Heckert, BS, Sean Harbison, MD, Henry P. Parkman, MD,
FACG, Temple University, Philadelphia, PA
68. Colorectal Cancer Patients Have Higher Rates of Advanced
Features in Their Diminutive Adenomas Compared to Patients
Undergoing Average-Risk Screening
Amoah Yeboah-Korang, MD, MPH, MSc, Philip Vutien, MD, Kateri
Evans, MS, Michael Greenspan, MD, Sohrab Mobarhan, MD,
Shriram Jakate, MD, Joshua Melson, MD, MPH, Rush University
Medical Center, Chicago, IL
10:45 am – 11:00 am Break
11:00 am – 12:15 pm Simultaneous Symposia 5
simultaneous symposia 5a:The
Inpatient Hepatology
Consult
moderator: Mark W. Russo, MD, MPH, FACG
Fluid, Distention, Infection, Oh My: Approach to the Patient
With Ascites
Mark W. Russo, MD, MPH, FACG
Treat patients with massive ascites and spontaneous bacterial
peritonitis.
69. Insertion Water Exchange Minimizes Endoscopist
Multitasking During Withdrawal Inspection: A Plausible
Explanation for Enhanced Polyp Detection in the Right Colon
Andrew Yen, MD, FACG, Victoria Y. Yung, MD, Joseph W. Leung,
MD, MACG, Surinder Mann, MD, FACG, Machelle D. Wilson,
PhD, Felix W. Leung, MD, FACG, Sacramento VA Medical Center,
VANCHCS, Mather, CA, University of California, Davis Medical
Center, Sacramento, CA, Sepulveda Ambulatory Care Center,
VAGLAHS, North Hills, CA
Water, Water Everywhere: Approach to the Cirrhotic Patient With
Acute Kidney Injury
Jasmohan S. Bajaj, MD, FACG
Evaluate the cirrhotic patient with acute kidney injury, including hepatorenal
syndrome, acute kidney injury and hyponatremia.
70. Comparing Diagnostic Tests in Dyssynergic DefecationConstipation
Danse Bi, MD, Sandra Sostrich, MD, Mojtaba Olyaee, MD, Elena
Sidorenko, MD, Tuba Esfandyari, MD, University of Kansas Medical Center, Kansas City, KS
A Rational Guide to the Use of TIPS
Atif Zaman, MD, FACG
Discuss appropriate indications for TIPS referrals and manage post-TIPS
complications.
71. Clostridium difficile Associated Risk of Death Score
(CARDS): A Novel Risk Score to Predict Mortality Among Hospitalized Patients With Clostridium difficile Infection
Zain Kassam, MD, MPH, Camila Cribb Fabersunne, MD, MPH
Candidate, Mark B. Smith, MD, PhD Candidate, Gilaad G. Kaplan, MD, MPH, Geoffrey C. Nguyen, MD, PhD, Ashwin N. Ananthakrishnan, MBBS, MPH, Massachusetts Institute of Technology,
Cambridge, MA, Harvard Medical School, Boston, MA, University
of Calgary, Calgary, Alberta, Canada, University of Toronto, Toronto, Ontario, Canada, Massachusetts General Hospital, Boston, MA
simultaneous symposia 5b:The
Human Microbiome
moderator: Eamonn M. M. Quigley, MD, FACG
Human Intestinal Microbiome: What the Practicing
Gastroenterologist Should Know
Eamonn M. M. Quigley, MD, FACG
Identify how the microbiome functions and interacts within the GI
tract.
What Is the Evidence that the Intestinal Microbiome Has a Role in
Gastrointestinal Diseases?
Lawrence J. Brandt, MD, MACG
72. Fresh, Frozen, or Lyophilized Fecal Microbiota Transplantation (FMT) for Multiple Recurrent C. difficile Infection (CDI)
Zhi-Dong Jiang, PhD, Nadim J. Ajami, PhD, Todd Lasco, PhD,
Joe Petrosino, PhD, Fredric Hochman, MD, Victor Ankoma-Sey,
MD, Matthew Wong, PhD, Ashley Alexander, MS, Shi Ke, MS,
Herbert L. DuPont, MD, University of Texas SPH, Houston, TX,
Baylor College of Medicine, Houston, TX, Baylor St. Luke’s Medical Center, Houston, TX
Define the role of the human microbiome in relation to GI disorders.
Targeting the Intestine Microbiota in the Treatment of
Gastrointestinal Diseases
Yehuda Ringel, MD, FACG
Assess the role of the human microbiome in the treatment of GI diseases.
12:15 pm
David Y. Graham Lecture
36
ANNUAL SCIENTIFIC MEETING ADJOURNS

ACG's 2014 Annual Scientific Meeting Annual Scientific Meeting

Transcription

Similar documents

48th Annual Gastroenterology Update Treatment of Special Cases Course Overview Featured Lectures

2011 Florida ACG/FGS Spring Symposium

Choledocolithiasis Choledocolithiasis

Williamsburg - American College of Gastroenterology

Esophageal Motility Disorders-2015

IBSi 2015 Wh t` N d IBS in 2015: What`s New and What Works?

How To Avoid Coding Errors

Overcoming Implementing Increasing Cooperating

Hospital-Wide Awards $2,500 Team Awards (2) Poster #